Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction to chronic hepatitis B infection.

Teresa L Wright1

  • 1University of California-San Francisco, and VA Medical Center 111B, San Francisco, CA 94121, USA.

The American Journal of Gastroenterology
|February 2, 2006
PubMed
Summary

Chronic hepatitis B virus (HBV) infection impacts millions globally, leading to severe liver disease. While treatments exist, preventing and managing complications like liver cancer remain critical challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy <i>Arsa</i> Knock-Out Mice.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2023
Same author

Adeno-Associated Virus Gene Therapy for Liver Disease.

Human gene therapy·2016
Same author

Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.

Toxicological sciences : an official journal of the Society of Toxicology·2016
Same author

Workshop Proceedings: Streamlined Development of Safety Assessment Programs Supporting Orphan/Rare Diseases-Are We There Yet?

International journal of toxicology·2016
Same author

Proof of concept for a banding scheme to support risk assessments related to multi-product biologics manufacturing.

Regulatory toxicology and pharmacology : RTP·2015
Same author

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

Gynecologic oncology·2015

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic hepatitis B virus (HBV) infection affects over 350 million people worldwide, causing over 1 million deaths annually from liver disease.
  • Infection can lead to cirrhosis, liver failure, and hepatocellular carcinoma (HCC) in up to 40% of patients, despite eventual nonreplicative states.
  • Transmission modes vary globally, with perinatal and early childhood infection common in endemic areas, and horizontal/sexual transmission prevalent in lower-prevalence regions like the US.

Purpose of the Study:

  • To summarize the global impact of chronic hepatitis B virus (HBV) infection.
  • To outline factors influencing disease progression and chronic infection risk.
  • To review current treatment strategies and identify unmet needs in managing HBV-related liver disease and HCC.

Main Methods:

Related Experiment Videos

  • Literature review of HBV epidemiology, transmission, risk factors, and treatment modalities.
  • Analysis of host, viral, and external factors affecting disease progression.
  • Evaluation of current FDA-approved antiviral therapies and their impact on HBV natural history.

Main Results:

  • Disease progression is influenced by host factors (age, gender, immune status), viral factors (load, genotype, mutations), and external factors (co-infections, alcohol, chemotherapy).
  • Perinatal transmission, the most common mode, can be significantly reduced by infant prophylaxis (vaccination and HBIG).
  • Current antiviral therapies improve the natural history of HBV, but strategies for preventing and treating HCC remain insufficient.

Conclusions:

  • Effective prophylaxis can reduce perinatal HBV transmission.
  • Antiviral therapies improve outcomes for chronic HBV infection, but liver transplantation is often necessary for advanced disease.
  • Further advancements are needed in the prevention and treatment of HBV-related hepatocellular carcinoma.